Search All News
Only select neurons die during Parkinson’s disease. Columbia researchers are looking for clues in immune cells to find out what makes these brain cells so vulnerable.
With several targeted Parkinson’s disease drugs entering clinical trials, a new genetic testing and counseling program may help identify patients who qualify for enrollment.
Survivors of cardiac arrest are more likely to experience further heart trouble if they have symptoms of PTSD, according to a new study from researchers at Columbia University Irving Medical Center.
- September 18, 2017
A cellular defense against protein aggregates suppresses ALS in early stages but later hastens spread of the disease, a study in mice suggests.
- September 1, 2017
With miniature mobile microscopes, Columbia neuroscientists have uncovered a map deep in the brain that guides movement in mice.
- August 29, 2017
Age-related memory loss was reversed by boosting blood levels of osteocalcin, a hormone produced by bone cells, in mice.
- July 26, 2017
Columbia neurologist Denise Chou, MD, explains a new breakthrough in headache medicine: the first targeted preventive therapy for migraine.
- July 17, 2017
A new study suggests how nutrients found in brain-healthy foods can reduce inflammation and lower Alzheimer's risk.
- June 21, 2017
Researchers have found the first direct evidence that autoimmunity plays a role in Parkinson’s disease.
- May 25, 2017
Certain women with preeclampsia are more likely to have a pregnancy-related stroke, finds a new study led by Columbia neurologists.
- May 19, 2017
Neurosurgeon Sameer Sheth uses deep brain stimulation to treat depression in patients who have not been helped with other therapies.
- May 15, 2017
Spinal muscular atrophy is partly due to defects in the sensory neuron synapses that activate motor neurons. Symptoms may be reduced by improving synapse function.